Impact report 2024

Mother holds two young children in her arms
Headshot of James Tibenderana, Chief Executive of Malaria Consortium

James Tibenderana, Chief Executive

James Tibenderana, Chief Executive

Message from the Chief Executive

It is a privilege to share our key achievements in the past year with you — a year in which Malaria Consortium marked its 20th anniversary as a UK-registered international charity. We are grateful to be bolstered by the passion and commitment of amazing colleagues and stakeholders to our organisational mission who help us achieve our successes and translate them into impact for the communities with whom we work. As a global NGO, our true strength lies in working closely with diverse stakeholders that help us to learn, adapt and deliver lasting value.

A common thread in the report are the linkages between quality, access and equity in the work that we do. We strive for positive and sustained impact by maximising these and see the pathways where extending our core competences in malaria control and elimination can inform other aspects in global health — such as antimicrobial resistance (AMR), climate change, cervical cancer, vaccination, and sexual and reproductive health. Our proximity to communities and national stakeholders requires us to adapt to the changing public health needs they face, comprising both current and emerging health risks including insecticide and drug resistance, direct and indirect effects of climate change on health, and arboviral diseases. These and other challenges make achieving optimal and sustained impact easier said than done.

Nonetheless, we continually seek and see important opportunities to do more with the capabilities we have, the funding that we can secure, the partners and stakeholders with whom we work, and the communities who place their trust in us to deliver cost-effective programmes. We envisage  opportunities to co-deliver synergistic health interventions, leveraging economies of scale and/or scope, getting better at adapting to our operating environment and strengthening our capacity to deliver value for communities most at risk of communicable diseases or who are hard-to-reach due to barriers such as geographical location.

We are hugely grateful to all those who make it possible for us to secure funding for our programmes, to national governments and their development partners who value our capabilities and the communities we work alongside. As we come to the end of our current organisational strategy in 2025, we are excited about launching our next strategy because we see the role we can play in addressing the current and emerging gaps for equitable access to quality health services. I would like to personally acknowledge and thank my colleagues in Malaria Consortium who work tirelessly to achieve our mission.  

Message from the Global Technical Director

As I reflect on the remarkable progress we’ve made this year in advancing malaria and public health programmes, it is clear that the quality and effectiveness of our programmes remains at the forefront of our mission. At Malaria Consortium, our commitment to delivering high-quality, evidence-based interventions has driven innovative approaches that continue to make significant impacts in the communities we work alongside.

This year, we have continued to strengthen programme quality, ensuring that our interventions not only adhere to the highest standards but are also adaptable to the evolving landscape of malaria control and health systems strengthening. The effectiveness of our interventions directly impacts the health outcomes of families and of individuals who otherwise do not have access to the services they need. Through rigorous evaluation and continuous improvement, we have enhanced our strategies to ensure they are not only evidence-based but also culturally sensitive and sustainable. From scaling up the use of digital tools for real-time data collection to improving integrated services, we’ve embraced innovation to enhance efficiency and outcomes.

A cornerstone of our work has been the deepening of local partnerships. By collaborating closely with governments, local health authorities and local organisations, we’ve fostered sustainable approaches that empower individuals, families and communities to more effectively influence their own health outcomes. These collaborative partnerships are critical to achieving success in malaria elimination efforts and are key to fostering resilient health systems for the long term.

Our commitment to delivering equitable solutions means we are using this collective approach to implement innovative, contextualised solutions that address the unique challenges and needs of the most vulnerable populations, including remote communities, children under five and pregnant women. We have also increased our integrated programming and focus to better ensure services provide a whole-health approach to quality improvement.

Together, we move forward toward a healthier, malaria-free future.

Headshot of Katherine Theiss-Nyland, Global Technical Director

Katherine Theiss-Nyland, Global Technical Director

Katherine Theiss-Nyland, Global Technical Director

Malaria Consortium is one of the world’s leading non-profit organisations specialising in the prevention, control and treatment of malaria and other communicable diseases.

Our mission is to save lives and improve health in Africa and Asia through evidence-based programmes that combat targeted diseases and promote universal health coverage.